openPR Logo
Press release

Clinical Trial Management System market outlook with industry review and forecasts

02-27-2018 07:44 AM CET | IT, New Media & Software

Press release from: Global Market Insights, Inc.

Clinical Trial Management Systems market is booming with the pharmaceutical and medical devices companies investing significantly in research & development projects. Pharmaceutical and biopharmaceutical companies accounted for more than 60% of the overall Clinical Trial Management Systems revenue share in 2015, and is projected to exceed USD 1.4 billion by 2024. The major industry competitors are ploughing back their profits into research to stay ahead of their competitors. These players are focusing on their core competencies and outsourcing of clinical trial processes, which is helping CTMS market to impel momentously over the coming seven years.

Growing prevalence of chronic diseases is resulting into rising deployment of CTMS, which can maintain and manage the planning, data collection, reporting, and tracking deadlines. CTMS being a software solution, has its application in biotechnology and pharmaceutical industries for effective management. As per a report by Global Market Insights Inc., “ Clinical Trial Management Systems Market (CTMS) Market is forecast to surpass a value of USD 2.4 billion by 2024.”

Request sample copy @ https://www.gminsights.com/request-sample/detail/1155

Over the recent years, the growth in the sales of components has seen an upsurge due to the growing trend of outsourcing clinical trials by pharmaceutical companies. CTMS includes hardware, software, and services in terms of components.

• Hardware market worth USD 90 million in 2015, is projected to register a CAGR of 13% over the period of 2016-2024.

• Software market is estimated to exceed a revenue of over USD 1.5 billion by 2024, having had 65% share of the Clinical Trial Management Systems market in 2015.

• Services component market is anticipated to grow at a rate of 14.2% over the period of 2016-2024.

Clinical Trial Management Systems based on type of products, is bifurcated into enterprise and site based CTMS.
• Site based Clinical Trial Management Systems market is likely to register a CAGR of over 13% over the period of 2016-2024. In terms of revenue generation, it is predicted to surpass USD 650 million by 2024.

• Enterprise based CTMS industry share is anticipated to grow at a rate of 13.8% from 2016-2024 and will surpass a value over USD 1.7 billion by 2024. These products are equipped with superior in-house clinical trial management capabilities. This system also allows multiple users to simultaneously access data.

Most recently, the term eClinics has evolved to encompass the entire business process with the help of developing technologies. A number of relevant applications have increased with the rising adoption of the web, on premise, and cloud based delivery modes.
• In 2015, web based delivery mode accounted for 60% of Clinical Trial Management Systems industry share, owing to faster, easier, and cost-effectiveness of this CTMS delivery mode.

• On premise CTMS market worth USD 170 million in 2015, is anticipated to exceed USD 450 million by 2024. This delivery mode is a striking solution for confidentiality and data privacy.

• Cloud based CTMS industry, being another lucrative segment, is expected to grow at a rate of 15.5% over the period of 2016-2024.

The regional insights influencing Clinical Trial Management Systems industry share are as mentioned below:
• Europe CTMS market is estimated to witness a Y-O-Y growth rate of 12.6% from 2016-2024, owing to favorable government initiatives and a rising focus on development of novel drugs to treat chronic diseases.

• China Clinical Trial Management Systems market is anticipated to register a double digit CAGR of 20.7% over the period of 2016-2024.

• U.S. government initiatives to develop novel healthcare solutions will fuel the CTMS industry growth. The regional market size is slated to surpass USD 780 million by 2024.

• Brazil Clinical Trial Management Systems industry is estimated to exceed USD 55 million by 2024 and register a CAGR of 17.5% over the period of 2016-2024. Rising demand for novel technologies and growing adoption of biomedical devices are the attributing factors for the regional development.

• India CTMS market worth USD 50 million in 2015, is projected to grow at a rate of 22% between 2016-2024, owing to rising awareness toward conducting clinical trials.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1155

Key industry participants accumulating significant industry share include Oracle Corporation, PAREXEL International Corporation, eClinForce, MedNet Solutions Forte Research Systems, Merge Healthcare, DATATRAK International, Bio-Optronics, BioClinica, Medidata solutions, DSG, and VEEVA Systems.

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trial Management System market outlook with industry review and forecasts here

News-ID: 958658 • Views:

More Releases from Global Market Insights, Inc.

Hepatitis B Vaccine Market Set to Surpass $12 Billion by 2034
Hepatitis B Vaccine Market Set to Surpass $12 Billion by 2034
The global hepatitis B vaccine market is poised for significant expansion over the next decade, fueled by rising liver disease cases, expanded immunization coverage, and advancements in vaccine development. Valued at USD 6.7 billion in 2024, the market is projected to reach USD 7.3 billion in 2025 and surge to USD 12 billion by 2034, reflecting a healthy compound annual growth rate (CAGR) of 5.7%. A major driver behind this growth
Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health. This in turn has led to a surge in demand for various functional foods
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock. According to Global Market Insights Inc estimates
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key players Eaton, Schneider, Siemens, Hitachi, Powell, Hubbell
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3091 Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group

All 5 Releases


More Releases for CTMS

Key Trends Shaping the Future Clinical Trial Management System CTMS Market From …
What Is the Estimated Market Size and Growth Rate for the Clinical Trial Management System CTMS Market? The clinical trial management system (CTMS) market has experienced rapid growth in recent years. It is expected to grow from $1.41 billion in 2024 to $1.61 billion in 2025, with a CAGR of 14.2%. Growth factors include increasing clinical trial complexity, a rise in global clinical trials, regulatory compliance demands, an increasing focus on
Clinical Trial Management System (CTMS) Market: Growth, Trends, Opportunities, a …
Introduction A Clinical Trial Management System (CTMS) is an integrated software platform designed to streamline and manage the planning, execution, and monitoring of clinical trials. It helps healthcare organizations, pharmaceutical companies, research institutions, and contract research organizations (CROs) efficiently oversee the complex and data-driven processes of clinical trials. The CTMS enables management of trial activities such as patient recruitment, data collection, regulatory compliance, budgeting, and reporting. Clinical trials are a critical component
Clinical Trial Management System (CTMS) Market: Growth, Opportunities, and Chall …
Introduction The Clinical Trial Management System (CTMS) market is a crucial segment of the global healthcare and pharmaceutical industries, which supports the efficient and accurate management of clinical trials. CTMS refers to software systems used by pharmaceutical, biotechnology, and contract research organizations (CROs) to streamline the planning, tracking, and management of clinical trials. These systems provide centralized data management for clinical trial activities, which helps improve the speed, quality, and compliance
Clinical Trial Management System (CTMS) Global Market Report 2024 - Clinical Tri …
"The Business Research Company recently released a comprehensive report on the Global Clinical Trial Management System (CTMS) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The
Clinical Trial Management System (CTMS) Market Scope & Future Opportunities Till …
An exclusive Clinical Trial Management System (CTMS) Market research report has been fabricated through the in depth analysis of the market dynamics across five regions including North America, Europe, South America, Asia-Pacific, Middle East and Africa. The segmentation of the market by components, end users, and region was done based on the thorough market analysis and validation through extensive primary inputs from industry experts (key opinion leaders of companies, and
Latest Clinical Trial (CTMS) Market 2022 | Detailed Report
ReportsnReports publishes the report titled Clinical Trial (CTMS) that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like